Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab
Lukáš Smolej 4th Department of Internal Medicine – Hematology, University Hospital Hradec Králové and Charles University in Prague, Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic...
Saved in:
Main Author: | Smolej L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical application of obinutuzumab for treating chronic lymphocytic leukemia
by: Luan C, et al.
Published: (2019) -
New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumab
by: Shah A
Published: (2015) -
Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy
by: Al-Sawaf O, et al.
Published: (2017) -
Obinutuzumab in a patient with chronic lymphocytic leukemia-associated paraneoplastic pemphigus
by: Johanna Freund, MD, et al.
Published: (2022) -
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
by: Casado LF, et al.
Published: (2016)